国际医药卫生导报
國際醫藥衛生導報
국제의약위생도보
INTERNATIONAL MEDICINE & HEALTH GUIDANCE NEWS
2013年
22期
3383-3386
,共4页
慢性鼻-鼻窦炎%内窥镜鼻窦手术%中医辨证治疗
慢性鼻-鼻竇炎%內窺鏡鼻竇手術%中醫辨證治療
만성비-비두염%내규경비두수술%중의변증치료
Chronic rhinosinusitis%Endoscopic sinus surgery (ESS)%Syndrome differentiation of traditional Chinese medicine
目的 探讨慢性鼻-鼻窦炎内窥镜鼻窦手术术后中医辨证治疗的主客观疗效.方法 选择2011年1月至2012年10月在我院住院治疗的慢性鼻窦炎患者105例(192侧).以数字法分成观察组和对照组两个组别,其中对照组53例,共计98侧.观察组52例,共计94侧.观察组在实施内窥镜下鼻窦手术之后通过中医辨证方案进行治疗,而对照组则在手术后不采用中医辨证方案进行治疗.对比两组患者在术后疗效、上皮化时间、VAS评分情况.结果 观察组治疗无效数据为5例(9.6％),低于对照组16例(30.2％)；且观察组治疗改善率47例(90.3％)显著高于对照组37例(69.8％),差异有统计学意义(P＜0.05).而观察组治愈23例(44.2％),好转24例(46.2％),对比于对照组分别数据16例(30.2％),21例(39.6％),差异无统计学意义(P＞0.05).观察组上皮化时间(46.7±12.6)d,少于对照组(58.6± 16.8)d.差异有统计学意义(P＜0.05).观察组在治疗后VAS评分为(2.31±0.98)低于对照组(3.25±1.12),差异有统计学意义(P＜0.05).结论 中医辨证治疗慢性鼻-鼻窦炎内窥镜鼻窦手术术后效果显著,促进上皮化,改善患者主观症状,值得临床推荐.
目的 探討慢性鼻-鼻竇炎內窺鏡鼻竇手術術後中醫辨證治療的主客觀療效.方法 選擇2011年1月至2012年10月在我院住院治療的慢性鼻竇炎患者105例(192側).以數字法分成觀察組和對照組兩箇組彆,其中對照組53例,共計98側.觀察組52例,共計94側.觀察組在實施內窺鏡下鼻竇手術之後通過中醫辨證方案進行治療,而對照組則在手術後不採用中醫辨證方案進行治療.對比兩組患者在術後療效、上皮化時間、VAS評分情況.結果 觀察組治療無效數據為5例(9.6％),低于對照組16例(30.2％)；且觀察組治療改善率47例(90.3％)顯著高于對照組37例(69.8％),差異有統計學意義(P＜0.05).而觀察組治愈23例(44.2％),好轉24例(46.2％),對比于對照組分彆數據16例(30.2％),21例(39.6％),差異無統計學意義(P＞0.05).觀察組上皮化時間(46.7±12.6)d,少于對照組(58.6± 16.8)d.差異有統計學意義(P＜0.05).觀察組在治療後VAS評分為(2.31±0.98)低于對照組(3.25±1.12),差異有統計學意義(P＜0.05).結論 中醫辨證治療慢性鼻-鼻竇炎內窺鏡鼻竇手術術後效果顯著,促進上皮化,改善患者主觀癥狀,值得臨床推薦.
목적 탐토만성비-비두염내규경비두수술술후중의변증치료적주객관료효.방법 선택2011년1월지2012년10월재아원주원치료적만성비두염환자105례(192측).이수자법분성관찰조화대조조량개조별,기중대조조53례,공계98측.관찰조52례,공계94측.관찰조재실시내규경하비두수술지후통과중의변증방안진행치료,이대조조칙재수술후불채용중의변증방안진행치료.대비량조환자재술후료효、상피화시간、VAS평분정황.결과 관찰조치료무효수거위5례(9.6％),저우대조조16례(30.2％)；차관찰조치료개선솔47례(90.3％)현저고우대조조37례(69.8％),차이유통계학의의(P＜0.05).이관찰조치유23례(44.2％),호전24례(46.2％),대비우대조조분별수거16례(30.2％),21례(39.6％),차이무통계학의의(P＞0.05).관찰조상피화시간(46.7±12.6)d,소우대조조(58.6± 16.8)d.차이유통계학의의(P＜0.05).관찰조재치료후VAS평분위(2.31±0.98)저우대조조(3.25±1.12),차이유통계학의의(P＜0.05).결론 중의변증치료만성비-비두염내규경비두수술술후효과현저,촉진상피화,개선환자주관증상,치득림상추천.
Objective To discuss the syndrome differentiation of traditional Chinese medicine (SDTCM)'s objective and subjective curative effect observation of chronic rhinosinusitis after endoscopic sinus surgery (ESS).Methods We chose 105 cases (192 sides) treated by surgery from January 2011 to October 2012 in our hospital.The cases were divided into 2 groups,observation group and control group by digital method.The control group included 53 cases of patients (98 sides),and the observation group included 52 cases of patients (94 sides).The observation was treated with SDTCM after ESS,while the control group was not.Curative effect was compared in the 2 groups,epithelial time and VAS score.Results The observation group' s treatment of invalid data was 5(9.6％),significantly lower than that of the control group as 16(30.2％).The observation group' s treatment improved rate of 47(90.3％) was significantly higher than that in control group of 37(69.8％).The difference was statistically significant (P ＜ 0.05).The observation group patients were cured in 23(44.2％),improvement in 24 (46.2％),compared with control group each data of 16(30.2％),21(39.6％).The difference was not statistically significant (P ＞ 0.05).The epithelial time of observation group of (46.7 ± 12.6) d,was significantly lower than that of the control group as (58.6 ± 16.8) d.The difference was statistically significant (P ＜ 0.05).The observation group' s VAS score was (2.31 ± 0.98) after treatment,which was significantly lower than that of the control group of (3.25 ± 1.12).The difference was statistically significant (P ＜ 0.05).Conclusion SDTCM has significant effect in treating patients of chronic rhinosinusitis after ESS,improves patients' epithelial changing,and their subjective symptoms,which is worthy of clinic recommendation.
